CTA-382

N/A

Report date: 2025/02/08 15:01:11
NME

Base Information

Drug NameCTA-382
Drug Alias NameCTA-382
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOvarian cancer G-protein coupled receptor 1 inhibitors
TargetsOvarian cancer G-protein coupled receptor 1
Therapy Area/IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCerta Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCerta Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A